Spotlight on NKG2C and the human NK-cell response to CMV infection

European Journal of Immunology

Volumn 42, Issue 12, 2012, Pages 3141-3145

  Malmberg, Karl Johan ^a,b,c   Beziat, Vivien ^a   Ljunggren, Hans Gustaf ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Cytomegalovirus; Immune responses; Infectious diseases; Innate immunity; NK cells; NKG2C

Indexed keywords

NKG2C RECEPTOR; RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; ASYMPTOMATIC INFECTION; CELL EXPANSION; COHORT ANALYSIS; COPY NUMBER VARIATION; CYTOMEGALOVIRUS INFECTION; GENE DELETION; HETEROZYGOSITY; HUMAN; NATURAL KILLER CELL; PRIORITY JOURNAL;

CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; KILLER CELLS, NATURAL; MALE; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C;

EID: 84871282021     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201243050     Document Type: Article

References (34)

1. Barrow, A. D. and Trowsdale, J., The extended human leukocyte receptor complex: diverse ways of modulating immune responses. Immunol. Rev. 2008. 224: 98-123.
2. Lazetic, S., Chang, C., Houchins, J. P., Lanier, L. L. and Phillips, J. H., Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J. Immunol. 1996. 157: 4741-4745.
3. Carretero, M., Cantoni, C., Bellon, T., Bottino, C., Biassoni, R., Rodriguez, A., Perez-Villar, J. J. et al., The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules. Eur. J. Immunol. 1997. 27: 563-567.
4. Houchins, J. P., Lanier, L. L., Niemi, E. C., Phillips, J. H. and Ryan, J. C., Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C. J. Immunol. 1997. 158: 3603-3609.
5. Lanier, L. L., Corliss, B., Wu, J. and Phillips, J. H., Association of DAP12 with activating CD94/NKG2C NK cell receptors. Immunity 1998. 8: 693-701.
6. Borrego, F., Ulbrecht, M., Weiss, E. H., Coligan, J. E. and Brooks, A. G., Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J. Exp. Med. 1998. 187: 813-818.
7. Braud, V. M., Allan, D. S., O'Callaghan, C. A., Soderstrom, K., D'Andrea, A., Ogg, G. S., Lazetic, S. et al., HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998. 391: 795-799.
8. Vales-Gomez, M., Reyburn, H. T., Erskine, R. A., Lopez-Botet, M. and Strominger, J. L., Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E. Embo. J. 1999. 18: 4250-4260.
9. Guma, M., Angulo, A., Vilches, C., Gomez-Lozano, N., Malats, N. and Lopez-Botet, M., Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 2004. 104: 3664-3671.
10. Beziat, V., Descours, B., Parizot, C., Debre, P. and Vieillard, V., NK cell terminal differentiation: correlated stepwise decrease of NKG2A and acquisition of KIRs. PloS One 2010. 5: e11966.
11. Bjorkstrom, N. K., Riese, P., Heuts, F., Andersson, S., Fauriat, C., Ivarsson, M. A., Bjorklund, A. T. et al., Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood 2010. 116: 3853-3864.
12. Juelke, K., Killig, M., Luetke-Eversloh, M., Parente, E., Gruen, J., Morandi, B., Ferlazzo, G. et al., CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells. Blood 2010. 116: 1299-1307.
13. + NK cells expressing self-specific KIRs in chronic hepatitis patients. Eur. J. Immunol. 2012. 42: 447-457.
14. +NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 2011. 108: 14725-14732.
15. + T cells. Eur. J. Immunol. 2005. 35: 2071-2080.
16. + NK cells in response to human cytomegalovirus-infected fibroblasts. Blood 2006. 107: 3624-3631.
17. Guma, M., Cabrera, C., Erkizia, I., Bofill, M., Clotet, B., Ruiz, L. and Lopez-Botet, M., Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients. J. Infect. Dis. 2006. 194: 38-41.
18. Bjorkstrom, N. K., Lindgren, T., Stoltz, M., Fauriat, C., Braun, M., Evander, M., Michaelsson, J. et al., Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J. Exp. Med. 2011. 208: 13-21.
19. Petitdemange, C., Becquart, P., Wauquier, N., Beziat, V., Debre, P., Leroy, E. M. and Vieillard, V., Unconventional repertoire profile is imprinted during acute chikungunya infection for natural killer cells polarization toward cytotoxicity. PLoS Pathog. 2011. 7: e1002268.
20. Brunetta, E., Fogli, M., Varchetta, S., Bozzo, L., Hudspeth, K. L., Marcenaro, E., Moretta, A. et al., Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection. AIDS 2010. 24: 27-34.
21. Kuijpers, T. W., Baars, P. A., Dantin, C., van den Burg, M., van Lier, R. A. and Roosnek, E., Human NK cells can control CMV infection in the absence of T cells. Blood 2008. 112: 914-915.
22. Della Chiesa, M., Falco, M., Podesta, M., Locatelli, F., Moretta, L., Frassoni, F. and Moretta, A., Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus? Blood 2012. 119: 399-410.
23. + natural killer cells with potent function. Blood 2012. 119: 2665-2674.
24. Hikami, K., Tsuchiya, N., Yabe, T. and Tokunaga, K., Variations of human killer cell lectin-like receptors: common occurrence of NKG2-C deletion in the general population. Genes Immun. 2003. 4: 160-167.
25. Moraru, M., Canizares, M., Muntasell, A., de Pablo, R., Lopez-Botet, M. and Vilches, C., Assessment of copy-number variation in the NKG2C receptor gene in a single-tube and characterization of a reference cell panel, using standard polymerase chain reaction. Tissue Antigens 2012. 80: 184-187.
26. Miyashita, R., Tsuchiya, N., Hikami, K., Kuroki, K., Fukazawa, T., Bijl, M., Kallenberg, C. G. et al., Molecular genetic analyses of human NKG2C (KLRC2) gene deletion. Int. Immunol. 2004. 16: 163-168.
27. Noyola, D. E., Fortuny, C., Muntasell, A., Noguera-Julian, A., Muñoz-Almagro, C., Alarcón, A., Juncosa, T. et al., Influence of congenital human cytomegalovirus infection and the NKG2C genotype on NK-cell subset distribution in children. Eur. J. Immunol. 2012. 42: 3256-3266.
28. Biron, C. A., Byron, K. S. and Sullivan, J. L., Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med. 1989. 320: 1731-1735.
29. Thomas, R., Low, H. Z., Kniesch, K., Jacobs, R., Schmidt, R. E. and Witte, T., NKG2C deletion is a risk factor of HIV infection. AIDS Re.s Hum. Retroviruses 2012. 28: 844-851.
30. Sabin, C. A., Phillips, A. N., Lee, C. A., Janossy, G., Emery, V. and Griffiths, P. D., The effect of CMV infection on progression of human immunodeficiency virus disease is a cohort of haemophilic men followed for up to 13 years from seroconversion. Epidemiol. Infect. 1995. 114: 361-372.
31. Cohen, G. B., Gandhi, R. T., Davis, D. M., Mandelboim, O., Chen, B. K., Strominger, J. L. and Baltimore, D., The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 1999. 10: 661-671.
32. Mocarski, E. S., Jr., Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion. Trends Microbiol. 2002. 10: 332-339.
33. Tomasec, P., Braud, V. M., Rickards, C., Powell, M. B., McSharry, B. P., Gadola, S., Cerundolo, V. et al., Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 2000. 287: 1031.
34. Kielczewska, A., Pyzik, M., Sun, T., Krmpotic, A., Lodoen, M. B., Munks, M. W., Babic, M. et al., Ly49P recognition of cytomegalovirus-infected cells expressing H2-Dk and CMV-encoded m04 correlates with the NK cell antiviral response. J. Exp. Med. 2009. 206: 515-523.